drug.â
âThe side-effects issue?â Crawford interrupted.
The Senate president announced that the voting would start. The call of the roll commenced.
âYes. I donât understand why weâre involved at all. Besides, the clinical trials showed an overall survival advantage.â
âWasnât there something about it not clearing all the phases . . . ?â He let that hang.
She explained. âFred said there were anomalies in the double-blind tests on patients who have tried other sources of therapy or medication. I understood there were some minor problems, but not with the drug itself, only in combination with people being treated for other diseases. Iâve read where thatâs not uncommon with drugs that are approved. Itâs been noted, but left up to the patientâs doctor to work out, if they can. On people without that complication, the results of this drug were miraculous. Now Fred says the FDA believes they were hidingââ
âI must admit,â he interrupted, âI havenât been paying a lot of attention . . . I mean, if there are clear advantages between those who used the miracle drug and those who didnâtââ He interrupted himself. âIs there something here Iâm not aware of?â
âI donât believe so,â she replied softly.
âI tend to go with the leadership on issues. Iâll check it out. Iâm meeting with Tom after the roll call; maybe I can findââ
âSenator Crawford,â called the clerk.
Crawford turned toward the dais. âYea.â He turned back to Dalton, who had on a different face. He glanced in the direction she was looking and saw Kelly engrossed in conversation with Pembroke.
âIâll get back to you later,â she said, and walked up the aisle.
What was that all about? Crawford sat at his desk. He had not been keeping up with the new drug. Heâd ask Gordon about it, hoping his AA would know.
Following Kellyâs vote, Crawford sought out the majority leader in the Cloakroom.
Kelly dispensed with the niceties. He gave Crawford a broad-brush background, hitting hard on his concerns. It was a drug that Kelly didnât name, but it fit into what Dalton had said.
Pembroke had joined them.
Kelly went on saying that the party needed unanimous support and that one senator was preventing that. âIâd like you to speak to this senator, Gavin, on behalf of the party.â
What happened to the whip? Crawford thought. Pembroke nodded in affirmation to the various points Kelly was making. Crawfordâs and Pembrokeâs families were friends. Their second homes were locally in McLean, and they traveled in the same circles. A few times in heavy snow, he and Pembroke had carpooled, using Pembrokeâs four-wheel-drive SUV. Crawfordâs little hybrid was overly challenged in that type of weather.
Kelly was saying, âWe have to be extremely careful with this. We donât want the FDA to rush approval on a so-called miracle drug only to find it is plagued with severe side effects.â
âWhat about clinical trials?â Crawford asked.
âThatâs just it,â Pembroke jumped in. âWe arenât sure about the validity of the testing.â
Crawford realized that this had to be about the drug Dalton had mentioned. âWhat does the pharmaceutical say?â
âWe need to support the FDA, have everyone on board,â Tom responded, ignoring Crawfordâs question.
That was a quick non-answer, he thought. âWhat about our friends across the aisle?â
âThey feel there are more critical issues facing us right now and donât want to get into a pissing match over one drug.â
Crawford didnât think that sounded like them.
Kelly went on. âWe have bigger fish to fry, such as prescription costs and Medicare discounts. We have a lot on our plate and donât need any